Maximizing anti-HBs seroresponsiveness in kidney transplant waitlist patients: A tertiary-center perspective
.

MLA

Udomkarnjananun, Suwasin, et al. “Maximizing Anti-HBs Seroresponsiveness in Kidney Transplant Waitlist Patients: A Tertiary-Center Perspective.” Clinical Nephrology, vol. 92, no. 4, Oct. 2019, pp. 190–200. EBSCOhost, https://doi.org/10.5414/CN109767.

APA

Udomkarnjananun, S., Townamchai, N., Wattanatorn, S., On-Yim, L., Vanichanan, J., Jutivorakool, K., Avihingsanon, Y., Praditpornsilpa, K., Eiam-Ong, S., & Leelahavanichkul, A. (2019). Maximizing anti-HBs seroresponsiveness in kidney transplant waitlist patients: A tertiary-center perspective
. Clinical Nephrology, 92(4), 190–200. https://doi.org/10.5414/CN109767

Chicago

Udomkarnjananun, Suwasin, Natavudh Townamchai, Salin Wattanatorn, Lalana On-Yim, Jakapat Vanichanan, Kamonwan Jutivorakool, Yingyos Avihingsanon, Kearkiat Praditpornsilpa, Somchai Eiam-Ong, and Asada Leelahavanichkul. 2019. “Maximizing Anti-HBs Seroresponsiveness in Kidney Transplant Waitlist Patients: A Tertiary-Center Perspective.” Clinical Nephrology 92 (4): 190–200. doi:10.5414/CN109767.